Nuclear Entry of Activated MAPK is Restricted in Primary Ovarian and Mammary Epithelial Cells

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2010 Feb 23

PMID 20174585

Citations 19

Authors

Elizabeth R Smith

Kathy Qi Cai

Jennifer L Smedberg

Melina M Ribeiro

Malgorzata E Rula

Carolyn Slater

Andrew K Godwin

Xiang-Xi Xu

Affiliations

Soon will be listed here.

Abstract

Background: The MAPK/ERK1/2 serine kinases are primary mediators of the Ras mitogenic signaling pathway. Phosphorylation by MEK activates MAPK/ERK in the cytoplasm, and phospho-ERK is thought to enter the nucleus readily to modulate transcription.

Principal Findings: Here, however, we observe that in primary cultures of breast and ovarian epithelial cells, phosphorylation and activation of ERK1/2 are disassociated from nuclear translocalization and transcription of downstream targets, such as c-Fos, suggesting that nuclear translocation is limited in primary cells. Accordingly, in import assays in vitro, primary cells showed a lower import activity for ERK1/2 than cancer cells, in which activated MAPK readily translocated into the nucleus and activated c-Fos expression. Primary cells express lower levels of nuclear pore complex proteins and the nuclear transport factors, importin B1 and importin 7, which may explain the limiting ERK1/2 import found in primary cells. Additionally, reduction in expression of nucleoporin 153 by siRNA targeting reduced ERK1/2 nuclear activity in cancer cells.

Conclusion: ERK1/2 activation is dissociated from nuclear entry, which is a rate limiting step in primary cells and in vivo, and the restriction of nuclear entry is disrupted in transformed cells by the increased expression of nuclear pores and/or nuclear transport factors.

Citing Articles

Evaluation of the Expression EGFR, HER2/NEU and the End Effector ERK of the RAS/RAF/MAP Kinase Pathway in Prostatic Adenocarcinoma for a Possible Role as New Target Therapy.

Shalaby A, Mahmoud H, Sayed S, Al Hashmi K, Al-Sinawi S, Al Badi S Asian Pac J Cancer Prev. 2024; 25(6):2193-2201.

PMID: 38918683 PMC: 11382872. DOI: 10.31557/APJCP.2024.25.6.2193.

A mass spectrometry-based approach for the identification of Kpnβ1 binding partners in cancer cells.

Okpara M, Hermann C, van der Watt P, Garnett S, Blackburn J, Leaner V Sci Rep. 2022; 12(1):20171.

PMID: 36418423 PMC: 9684564. DOI: 10.1038/s41598-022-24194-6.

The G Protein-Coupled Serotonin 1A Receptor Augments Protein Kinase Cε-Mediated Neurogenesis in Neonatal Mouse Hippocampus-PKCε-Mediated Signaling in the Early Hippocampus.

Samaddar S, Purkayastha S, Diallo S, Tantry S, Schroder R, Chanthrakumar P Int J Mol Sci. 2022; 23(4).

PMID: 35216076 PMC: 8878481. DOI: 10.3390/ijms23041962.

Immunohistochemical staining of phosphorylated-ERK in post-chemotherapeutic samples is a potential predictor of the prognosis of neuroblastoma.

Tanaka T, Togashi Y, Takeuchi Y, Higashi M, Fumino S, Tajiri T Pediatr Surg Int. 2021; 37(2):287-291.

PMID: 33394087 DOI: 10.1007/s00383-020-04806-w.

Importin β1 regulates cell growth and survival during adult T cell leukemia/lymphoma therapy.

Ishikawa C, Senba M, Mori N Invest New Drugs. 2020; 39(2):317-329.

PMID: 32959166 DOI: 10.1007/s10637-020-01007-z.

References

Lyman S, Gerace L . Nuclear pore complexes: dynamics in unexpected places. J Cell Biol. 2001; 154(1):17-20. PMC: 2196851. DOI: 10.1083/jcb.200106071. View

Mackay D, Elgort S, Ullman K . The nucleoporin Nup153 has separable roles in both early mitotic progression and the resolution of mitosis. Mol Biol Cell. 2009; 20(6):1652-60. PMC: 2655243. DOI: 10.1091/mbc.e08-08-0883. View

Whitehurst A, Robinson F, Moore M, Cobb M . The death effector domain protein PEA-15 prevents nuclear entry of ERK2 by inhibiting required interactions. J Biol Chem. 2004; 279(13):12840-7. DOI: 10.1074/jbc.M310031200. View

Harel A, Orjalo A, Vincent T, Lachish-Zalait A, Vasu S, Shah S . Removal of a single pore subcomplex results in vertebrate nuclei devoid of nuclear pores. Mol Cell. 2003; 11(4):853-64. DOI: 10.1016/s1097-2765(03)00116-3. View

Lorenzen J, Baker S, Denhez F, Melnick M, Brower D, Perkins L . Nuclear import of activated D-ERK by DIM-7, an importin family member encoded by the gene moleskin. Development. 2001; 128(8):1403-14. DOI: 10.1242/dev.128.8.1403. View

Brondello J, McKenzie F, Sun H, Tonks N, Pouyssegur J . Constitutive MAP kinase phosphatase (MKP-1) expression blocks G1 specific gene transcription and S-phase entry in fibroblasts. Oncogene. 1995; 10(10):1895-904. View

Fincham V, James M, Frame M, Winder S . Active ERK/MAP kinase is targeted to newly forming cell-matrix adhesions by integrin engagement and v-Src. EMBO J. 2000; 19(12):2911-23. PMC: 203361. DOI: 10.1093/emboj/19.12.2911. View

Matsubayashi Y, Fukuda M, Nishida E . Evidence for existence of a nuclear pore complex-mediated, cytosol-independent pathway of nuclear translocation of ERK MAP kinase in permeabilized cells. J Biol Chem. 2001; 276(45):41755-60. DOI: 10.1074/jbc.M106012200. View

Marais R, Wynne J, Treisman R . The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell. 1993; 73(2):381-93. DOI: 10.1016/0092-8674(93)90237-k. View

10.

Pouton C, Wagstaff K, Roth D, Moseley G, Jans D . Targeted delivery to the nucleus. Adv Drug Deliv Rev. 2007; 59(8):698-717. DOI: 10.1016/j.addr.2007.06.010. View

11.

Lin L, Wartmann M, Lin A, Knopf J, Seth A, Davis R . cPLA2 is phosphorylated and activated by MAP kinase. Cell. 1993; 72(2):269-78. DOI: 10.1016/0092-8674(93)90666-e. View

12.

Adachi M, Fukuda M, Nishida E . Two co-existing mechanisms for nuclear import of MAP kinase: passive diffusion of a monomer and active transport of a dimer. EMBO J. 1999; 18(19):5347-58. PMC: 1171604. DOI: 10.1093/emboj/18.19.5347. View

13.

James B, Bunch T, Krishnamoorthy S, Perkins L, Brower D . Nuclear localization of the ERK MAP kinase mediated by Drosophila alphaPS2betaPS integrin and importin-7. Mol Biol Cell. 2007; 18(10):4190-9. PMC: 1995703. DOI: 10.1091/mbc.e06-07-0659. View

14.

Martinez N, Alonso A, Moragues M, Ponton J, Schneider J . The nuclear pore complex protein Nup88 is overexpressed in tumor cells. Cancer Res. 1999; 59(21):5408-11. View

15.

Gille H, Sharrocks A, Shaw P . Phosphorylation of transcription factor p62TCF by MAP kinase stimulates ternary complex formation at c-fos promoter. Nature. 1992; 358(6385):414-7. DOI: 10.1038/358414a0. View

16.

Kumar J, Hsiung F, Powers M, Moses K . Nuclear translocation of activated MAP kinase is developmentally regulated in the developing Drosophila eye. Development. 2003; 130(16):3703-14. PMC: 2778067. DOI: 10.1242/dev.00556. View

17.

Ranganathan A, Yazicioglu M, Cobb M . The nuclear localization of ERK2 occurs by mechanisms both independent of and dependent on energy. J Biol Chem. 2006; 281(23):15645-52. DOI: 10.1074/jbc.M513866200. View

18.

Whitehurst A, Wilsbacher J, You Y, Luby-Phelps K, Moore M, Cobb M . ERK2 enters the nucleus by a carrier-independent mechanism. Proc Natl Acad Sci U S A. 2002; 99(11):7496-501. PMC: 124259. DOI: 10.1073/pnas.112495999. View

19.

Auersperg N, Wong A, Choi K, Kang S, Leung P . Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev. 2001; 22(2):255-88. DOI: 10.1210/edrv.22.2.0422. View

20.

Smith E, Smedberg J, Rula M, Xu X . Regulation of Ras-MAPK pathway mitogenic activity by restricting nuclear entry of activated MAPK in endoderm differentiation of embryonic carcinoma and stem cells. J Cell Biol. 2004; 164(5):689-99. PMC: 2172165. DOI: 10.1083/jcb.200312028. View